National Healthcare Properties, Inc. 10-Q

Item 4. Controls and Procedures. Evaluation of Disclosure Controls and Procedures Our Chief Executive Officer and Chief Financial Officer, together with other members of our management, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective as of September 30, 2025 at a reasonable level of assurance. Changes in Internal Control Over Financial Reporting During the three months ended September 30, 2025, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 54 PART II — OTHER INFORMATION Item 1. Legal Proceedings. We are not a party to, and none of our properties are subject to, any material pending legal proceedings. Item 1A. Risk Factors. There have been no material changes to the risk factors disclosed in Part I — Item 1A “ Risk Factors ” of our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025, and we direct your attention to those risk factors.